[PDF][PDF] Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus …

C Lourdudoss, S Ajeganova… - Clin Exp Rheumatol, 2018 - clinexprheumatol.org
Objective Immunoglobulin M (IgM) antibodies against phosphorylcholine (anti-PC) and
malondialdehyde (anti-MDA) are implicated in systemic lupus erythematosus (SLE) as …

IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus …

M Rahman, S Sing, Z Golabkesh, R Fiskesund… - Clinical …, 2016 - Elsevier
Objectives Phosphorylcholine (PC) and malondialdehyde (MDA) are generated during lipid
peroxidation and form adducts with proteins as albumin as studied herein. Atherosclerosis …

Immunoglobulin G1 antibodies against phosphorylcholine are associated with protection in systemic lupus erythematosus and atherosclerosis: potential underlying …

D Thiagarajan, R Fiskesund, A Frostegård… - ACR open …, 2020 - Wiley Online Library
Objective Immunoglobulin M antibodies against phosphorylcholine (anti‐PC s) may be
protective in atherosclerosis, cardiovascular disease (CVD), and systemic lupus …

Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus …

C Anania, T Gustafsson, X Hua, J Su… - Arthritis research & …, 2010 - Springer
Introduction The risk of cardiovascular disease (CVD) and atherosclerosis is reported to be
increased in systemic lupus erythematosus (SLE). We recently reported a negative …

IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases

D Thiagarajan, N Oparina, S Lundström, R Zubarev… - Scientific reports, 2020 - nature.com
IgM antibodies against phosphorylcholine (anti-PC) and malondialdehyde (anti-MDA) may
have protective properties in cardiovascular and rheumatic diseases. We here compare …

Natural antibodies against phosphorylcholine as potential protective factors in SLE

J Su, X Hua, H Concha, E Svenungsson… - …, 2008 - academic.oup.com
Objective. We have recently reported that natural antibodies against phosphorylcholine (anti-
PC) have atheroprotective properties. Here we compare anti-PC with other autoantibodies in …

Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies

R Ben Mansour, S Lassoued, A Elgaied… - Scandinavian journal …, 2010 - Taylor & Francis
Objective: Evaluation of the reactivity of autoantibodies of systemic lupus erythematosus
(SLE) patients directed against malondialdehyde (MDA)-modified catalase, superoxide …

Depressed serum IgM levels in SLE are restricted to defined subgroups

C Grönwall, U Hardt, JT Gustafsson, K Elvin… - Clinical …, 2017 - Elsevier
Natural IgM autoantibodies have been proposed to convey protection from autoimmune
pathogenesis. Herein, we investigated the IgM responses in 396 systemic lupus …

Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential …

U de Faire, J Su, X Hua, A Frostegård, M Halldin… - Journal of …, 2010 - Elsevier
OBJECTIVE: We here determine the role of IgM antibodies against phosphorylcholine (anti-
PC) in prediction of cardiovascular disease (CVD) and on macrophage uptake of Oxidized …

Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis

U Hardt, A Larsson, I Gunnarsson, RM Clancy… - Arthritis research & …, 2018 - Springer
Abstract Background Immunoglobulin M (IgM) autoreactivity to malondialdehyde (MDA)
protein modifications is part of the natural antibody repertoire in health and may have …